Abstracts tagged "Henoch-Schönlein purpura and vasculitis"

Abstract Number: 825 • 2018 ACR/ARHP Annual Meeting
Assessment of Damage and Prognosis in Patients with Adult IgA Vasculitis: Retrospective Multicentered Cohort Study
Ummugulsum Gazel¹, Ahmet Omma², Alper Sari³, Dondu Uskudar Cansu⁴, Ayten Yazici⁵, Ayse Cefle⁵, Cemal Bes⁶, Omer Karadag⁷, Haner Direskeneli⁸ and Fatma Alibaz-Oner¹, ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²Rheumatology, Ankara Numune Education and Research Hospital, Ankara, Turkey, ³Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁴Rheumatology, Osmangazi University, School of Medicine, Eskısehir, Turkey, ⁵Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey, ⁶Department of Rheumatology, Health Sciences University Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey, ⁷Rheumatology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ⁸Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: IgA Vasculitis is a leukocytoclastic vasculitis involving small vessels with depositions of immune complexes containing IgA. IgA Vasculitis is a predominantly pediatric vasculitis. There…
Abstract Number: 2718 • 2017 ACR/ARHP Annual Meeting
Is Smoking Important in Adult IgA Vasculitis?
Alojzija Hočevar¹, Ziga Rotar¹, Vesna Jurcic² and Matija Tomšič³, ¹Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ²Institute of Pathology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia, ³University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
Background/Purpose: Nicotine may predispose to kidney injury by increasing the oxidative stress, and there is known association between smoking and the progression of chronic kidney…
Abstract Number: 2961 • 2016 ACR/ARHP Annual Meeting
Antiphospoholipid Antibodies in Adult IgA Vasculitis: Aps/PT Antibodies As a Potential Marker of Renal Involvement?
Alojzija Hocevar, Jaka Ostrovrsnik, Polona Žigon, Saša Čučnik, Ziga Rotar and Matija Tomšič, Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Background/Purpose: Increased prevalence of IgA aCL and anti-PS/PT antibodies has been described in adult IgAV, making them potential markers of disease activity1. The aim of our…
Abstract Number: 1791 • 2014 ACR/ARHP Annual Meeting
Applicability of the 2006 European League Against Rheumatism (EULAR) Criteria for the Classification of Henoch-Schönlein Purpura. an Analysis Based on 766 Patients with Cutaneous Vasculitis
Montserrat Santos-Gómez¹, Francisco Ortiz Sanjuan¹, Jose L. Hernández², Marcos A. González-López³, Ricardo Blanco¹, Javier Loricera¹, Vanesa Calvo-Río¹, Trinitario Pina Murcia⁴, Carmen Gonzalez-Vela⁵, Marina Lacalle³, Javier Rueda-Gotor¹, Lino Álvarez⁶, Leyre Riancho-Zarrabeitia¹ and Miguel A. González-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ²Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ³Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ⁴Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, ⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ⁶Pediatrics, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain
Background/Purpose The European League Against Rheumatism (EULAR) proposed in 2006 a new classification criteria for Henoch-Schönlein Purpura (HSP). We aimed to establish the applicability of…
Abstract Number: 2635 • 2013 ACR/ARHP Annual Meeting
IgA Vasculitis In Adults – a Rare and Benign Disease?
Alojzija Hocevar¹, Jaka Ostrovrsnik¹, Vesna Jurcic² and Matija Tomsic^3,4, ¹Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ²Institute of Pathology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia, ³Department of Rheumatology, University Medical Centre Ljubjana, Ljubljana, Slovenia, ⁴Faculty of Medicine, Unversity Ljubljana, Ljubljana, Slovenia
Background/Purpose: IgA vasculitis (IgAV) is the most common vasculitis in children, with a defined epidemiology (14 cases/ 105children), clinical picture and generally favourable prognosis. In…
Abstract Number: 2636 • 2013 ACR/ARHP Annual Meeting
IgA Vasculitis – The Second Most Common Systemic Vasculitis In Adults In Slovenia
Alojzija Hocevar¹, ŽIga Rotar¹, Jaka Ostrovrsnik¹, Vesna Jurcic², Jelka Lindic³ and Matija Tomsic^4,5, ¹Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ²Institute of Pathology, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia, ³Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ⁴Department of Rheumatology, University Medical Centre Ljubjana, Ljubljana, Slovenia, ⁵Faculty of Medicine, Unversity Ljubljana, Ljubljana, Slovenia
Background/Purpose: IgA vasculitis (IgAV) is assumed to be rare in adults. Reported annual incidence rates vary between 0.8 and 1.8 cases per 100,000 adults.1 Our…
Abstract Number: 2634 • 2013 ACR/ARHP Annual Meeting
Henoch-Schönlein Purpura: Clinical Spectrum Of The Disease In 417 Patients From A Single Center
F. Ortiz-Sanjuán¹, Vanesa Calvo-Río², Javier Loricera¹, C Mata¹, L Martín Penagos³, L Alvarez⁴, M. Carmen González-Vela⁵, D González-Lamuño⁴, Javier Rueda-Gotor⁶, Héctor Fernández-Llaca⁷, Marcos A. González-López⁸, Susana Armesto⁹, M. Enriqueta Peiró², M. Arias³, Miguel Angel Gonzalez-Gay¹ and Ricardo Blanco¹⁰, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ²Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ³Nephrology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ⁴Pediatrics, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ⁵Pathology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ⁶Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, ⁷Dermatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ⁸Dermatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, ⁹Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ¹⁰Hospital Marques de Valdecilla, Santander, Spain
Background/Purpose: The severity of clinical features and the outcome in the different series of Henoch-Schönlein Purpura (HSP) shows great variability, probably due to selection-bias. Our…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].